161 related articles for article (PubMed ID: 16406867)
1. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
Donat SM; Salzhauer EW; Mitra N; Yanke BV; Snyder ME; Russo P
J Urol; 2006 Jan; 175(1):46-52. PubMed ID: 16406867
[TBL] [Abstract][Full Text] [Related]
2. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
3. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
[TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Yamasaki T; Kamba T; Kamoto T; Ogawa O
Urology; 2007 Jul; 70(1):50-4. PubMed ID: 17656207
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
[TBL] [Abstract][Full Text] [Related]
6. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
Schips L; Lipsky K; Zigeuner R; Gidaro S; Salfellner M; Rehak P; Pummer K; Hubmer G
J Surg Oncol; 2004 Nov; 88(2):57-61; discussion 61-2. PubMed ID: 15499606
[TBL] [Abstract][Full Text] [Related]
7. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
9. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
Hafron J; Mitra N; Dalbagni G; Bochner B; Herr H; Donat SM
J Urol; 2005 May; 173(5):1513-7. PubMed ID: 15821470
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
[TBL] [Abstract][Full Text] [Related]
11. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
[TBL] [Abstract][Full Text] [Related]
15. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
16. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
20. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
